Effects of orally administered antibiotics on the bioavailability of amlodipine: gutmicrobiota-mediated drug interaction
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Hye Hyun | - |
dc.contributor.author | Kim, In Sook | - |
dc.contributor.author | Yoo, Dae-Hyeong | - |
dc.contributor.author | Kim, Dong-Hyun | - |
dc.date.accessioned | 2021-06-22T17:24:57Z | - |
dc.date.available | 2021-06-22T17:24:57Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 0263-6352 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/14665 | - |
dc.description.abstract | Background: Amlodipine is a representative calcium channel blocker that is frequently prescribed for the treatment of hypertension. In this study, the possibility of drug-drug interactions between amlodipine and coadministered antibiotics (ampicillin) was investigated in rats; thus, changes in the metabolic activities of gut microflora and the consequent pharmacokinetic pattern of amlodipine following ampicillin treatment were characterized. Methods and results: In human and rat fecalase incubation samples, amlodipine was metabolized to yield a major pyridine metabolite. The remaining amlodipine decreased and the formation of pyridine metabolite increased with incubation time, indicating the involvement of gut microbiota in the metabolism of amlodipine. Pharmacokinetic analyses showed that systemic exposure of amlodipine was significantly elevated in antibiotic-treated rats compared with controls. Conclusion: These results showed that antibiotic intake might increase the bioavailability of amlodipine by suppressing gut microbial metabolic activities, which could be followed by changes in therapeutic potency. Therefore, coadministration of amlodipine with antibiotics requires caution and clinical monitoring. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
dc.title | Effects of orally administered antibiotics on the bioavailability of amlodipine: gutmicrobiota-mediated drug interaction | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoo, Hye Hyun | - |
dc.identifier.doi | 10.1097/HJH.0000000000000773 | - |
dc.identifier.scopusid | 2-s2.0-84950120270 | - |
dc.identifier.wosid | 000375228700021 | - |
dc.identifier.bibliographicCitation | Journal of Hypertension, v.34, no.1, pp.156 - 162 | - |
dc.relation.isPartOf | Journal of Hypertension | - |
dc.citation.title | Journal of Hypertension | - |
dc.citation.volume | 34 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 156 | - |
dc.citation.endPage | 162 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | CALCIUM-ANTAGONIST AMLODIPINE | - |
dc.subject.keywordPlus | DOSE-RESPONSE RELATIONSHIP | - |
dc.subject.keywordPlus | DOUBLE-BLIND EVALUATION | - |
dc.subject.keywordPlus | HUMAN PLASMA | - |
dc.subject.keywordPlus | HYPERTENSION | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | PHARMACOKINETICS | - |
dc.subject.keywordPlus | QUANTIFICATION | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordAuthor | amlodipine | - |
dc.subject.keywordAuthor | antibiotics | - |
dc.subject.keywordAuthor | bioavailability | - |
dc.subject.keywordAuthor | gut microbiota | - |
dc.subject.keywordAuthor | metabolism | - |
dc.identifier.url | https://oce.ovid.com/article/00004872-201601000-00022/HTML | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.